Kbc Group Nv Wave Life Sciences Ltd. Transaction History
Kbc Group Nv
- $36.3 Billion
- Q4 2024
A detailed history of Kbc Group Nv transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Kbc Group Nv holds 5,440 shares of WVE stock, worth $61,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,440Holding current value
$61,689% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
166Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$206 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$114 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$110 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$76.4 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$69.9 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $985M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...